Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO11394 | Dichroa febrifuga | Species | Hydrangeaceae | Eukaryota | HerDing* | |||
NPO18321 | Medicago sativa | Species | Fabaceae | Eukaryota | HerDing* | |||
NPO20168 | Melilotus albus | Species | Fabaceae | Eukaryota | HerDing* | |||
NPO22104 | Trifolium pratense | Species | Fabaceae | Eukaryota | HerDing* | |||
NPO30762 | Melilotus suaveolens | Species | Fabaceae | Eukaryota | HerDing* | |||
NPO31164 | Anthoxanthum sp | Species | Poaceae | Eukaryota | HerDing* | |||
NPO9111 | Gelatoporia subvermispora | Species | Coriolaceae | Eukaryota | UNPD* | |||
NPO11940 | Laurencia snyderiae | Species | Rhodomelaceae | Eukaryota | UNPD* | |||
NPO17085 | Dactylaria lutea | Species | Orbiliaceae | Eukaryota | UNPD* | |||
NPO14160 | Elaeis guineensis | Species | Arecaceae | Eukaryota | UNPD* | |||
NPO27176 | Anthoxanthum sp. | Species | Poaceae | Eukaryota | TCMID* | |||
NPO19849.1 | Melilotus officinalis subsp. suaveolens | Subspecies | Fabaceae | Eukaryota | TCMID* | |||
NPO22104 | Trifolium pratense | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO20168 | Melilotus albus | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO11394 | Dichroa febrifuga | Species | Hydrangeaceae | Eukaryota | TCMID* | |||
NPO18321 | Medicago sativa | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO12605 | Butea superba | Species | Fabaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | > | 100000 | nM | 9003523 |
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | > | 300000 | nM | 9003523 |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Ki | = | 1900 | nM | 14761192 |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Ki | = | 600 | nM | 10956186 |
NPT935 | Individual Protein | Quinone reductase 1) | Homo sapiens | IC50 | = | 450 | nM | 17011189 |
NPT2 | Others | Unspecified | IC50 | = | 3100 | nM | 17275317 | |
NPT935 | Individual Protein | Quinone reductase 1) | Homo sapiens | IC50 | = | 5 | nM | 17999461 |
NPT935 | Individual Protein | Quinone reductase 1) | Homo sapiens | IC50 | = | 450 | nM | 17999461 |
NPT783 | Cell Line | MIA PaCa-2 | Homo sapiens | Activity | = | 7 | nmol/min | 17999461 |
NPT783 | Cell Line | MIA PaCa-2 | Homo sapiens | IC50 | = | 75000 | nM | 17999461 |
NPT4885 | Individual Protein | Urease | Canavalia ensiformis | IC50 | = | 15135.61 | nM | 18280742 |
NPT5330 | Organism | Strongylocentrotus purpuratus | Strongylocentrotus purpuratus | Inhibition | = | 50 | % | 17614164 |
NPT2 | Others | Unspecified | Kd | = | 22000 | nM | 17614164 | |
NPT2 | Others | Unspecified | Ki | = | 50000 | nM | 18778048 | |
NPT3570 | Individual Protein | ATP phosphoribosyltransferase | Mycobacterium tuberculosis | Ki | = | 60000 | nM | 18778048 |
NPT935 | Individual Protein | Quinone reductase 1) | Homo sapiens | IC50 | = | 2.6 | nM | 19877692 |
NPT935 | Individual Protein | Quinone reductase 1) | Homo sapiens | IC50 | = | 404 | nM | 19877692 |
NPT783 | Cell Line | MIA PaCa-2 | Homo sapiens | IC50 | = | 90000 | nM | 19877692 |
NPT783 | Cell Line | MIA PaCa-2 | Homo sapiens | IC50 | = | 52000 | nM | 19877692 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 103000 | nM | 19877692 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 19000 | nM | 19877692 |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 50.1 | nM | PubChem BioAssay data set |
NPT210 | Individual Protein | Thyroid stimulating hormone receptor | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT213 | Individual Protein | Cytochrome P450 2C19 | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 6309.6 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 5011.9 | nM | PubChem BioAssay data set |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Potency | = | 25.1 | nM | PubChem BioAssay data set |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | AC50 | = | 25.12 | nM | PubChem BioAssay data set |
NPT213 | Individual Protein | Cytochrome P450 2C19 | Homo sapiens | AC50 | = | 10000 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | AC50 | = | 5011.87 | nM | PubChem BioAssay data set |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | AC50 | = | 12589.25 | nM | PubChem BioAssay data set |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Activity | = | 86.4 | % | 20869876 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Activity | = | 88.8 | % | 20869876 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Activity | = | 10.5 | % | 20869876 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Activity | = | 19.8 | % | 20869876 |
NPT2 | Others | Unspecified | IC50 | = | 4570 | nM | 21510613 | |
NPT620 | Individual Protein | Subtilisin/kexin type 7 | Homo sapiens | IC50 | = | 1300 | nM | 21510613 |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT68 | Individual Protein | Aldose reductase | Rattus norvegicus | IC50 | = | 4093 | nM | DrugMatrix in vitro pharmacology data |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | IC50 | = | 300 | nM | DrugMatrix in vitro pharmacology data |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | IC50 | = | 4426 | nM | DrugMatrix in vitro pharmacology data |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 8052.4 | nM | PubChem BioAssay data set | |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 12.27 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 5.48 | % | 23062825 |
NPT185 | Organism | Aspergillus flavus | Aspergillus flavus | MIC | >= | 2048 | ug/ml | 23306152 |
NPT87 | Organism | Aspergillus fumigatus | Aspergillus fumigatus | MIC | >= | 2048 | ug/ml | 23306152 |
NPT5161 | Individual Protein | Enoyl-[acyl-carrier-protein] reductase [NADH] | Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) | IC50 | = | 47000 | nM | 23815100 |
NPT1627 | Individual Protein | G-protein coupled receptor 35 | Homo sapiens | EC50 | = | 9780 | nM | 23888932 |
NPT1627 | Individual Protein | G-protein coupled receptor 35 | Homo sapiens | Ki | = | 39 | nM | 23888932 |
NPT1627 | Individual Protein | G-protein coupled receptor 35 | Homo sapiens | EC50 | = | 1300 | nM | 23888932 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 19.32 | % | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 33.08 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 13448.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9438.4 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 10123.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 5073.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2037.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 638.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11882.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6681.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7166.9 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 7497.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 7943.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11358.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1678.4 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 29847 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 5955.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4216 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5116.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3228.6 | nM | PubChem BioAssay data set | ||
NPT162 | Individual Protein | Heat shock protein beta-1 | Homo sapiens | Potency | 13332.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2285.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 507.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14299.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3757.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6007 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7497.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13333.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 5623.4 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC229113 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.8908 | High Similarity | NPC33717 |
0.8898 | High Similarity | NPC2989 |
0.877 | High Similarity | NPC31314 |
0.877 | High Similarity | NPC474874 |
0.877 | High Similarity | NPC193193 |
0.8718 | High Similarity | NPC141068 |
0.8672 | High Similarity | NPC238309 |
0.8651 | High Similarity | NPC168259 |
0.8615 | High Similarity | NPC307289 |
0.8615 | High Similarity | NPC281558 |
0.8582 | High Similarity | NPC71903 |
0.8527 | High Similarity | NPC474289 |
0.8519 | High Similarity | NPC170812 |
0.8462 | Intermediate Similarity | NPC32463 |
0.84 | Intermediate Similarity | NPC302107 |
0.8387 | Intermediate Similarity | NPC264976 |
0.8346 | Intermediate Similarity | NPC315807 |
0.8346 | Intermediate Similarity | NPC131950 |
0.8333 | Intermediate Similarity | NPC187868 |
0.8333 | Intermediate Similarity | NPC52247 |
0.832 | Intermediate Similarity | NPC247553 |
0.8319 | Intermediate Similarity | NPC149545 |
0.8281 | Intermediate Similarity | NPC89630 |
0.8271 | Intermediate Similarity | NPC287533 |
0.8268 | Intermediate Similarity | NPC311219 |
0.8258 | Intermediate Similarity | NPC137264 |
0.8248 | Intermediate Similarity | NPC310370 |
0.8248 | Intermediate Similarity | NPC183642 |
0.8231 | Intermediate Similarity | NPC258567 |
0.8231 | Intermediate Similarity | NPC121740 |
0.8231 | Intermediate Similarity | NPC224774 |
0.8222 | Intermediate Similarity | NPC223616 |
0.8217 | Intermediate Similarity | NPC88403 |
0.8211 | Intermediate Similarity | NPC51345 |
0.8182 | Intermediate Similarity | NPC115998 |
0.8182 | Intermediate Similarity | NPC39753 |
0.8168 | Intermediate Similarity | NPC469453 |
0.816 | Intermediate Similarity | NPC152306 |
0.8156 | Intermediate Similarity | NPC57470 |
0.8145 | Intermediate Similarity | NPC128633 |
0.8143 | Intermediate Similarity | NPC295696 |
0.814 | Intermediate Similarity | NPC193805 |
0.8136 | Intermediate Similarity | NPC139891 |
0.812 | Intermediate Similarity | NPC250727 |
0.8106 | Intermediate Similarity | NPC197425 |
0.8102 | Intermediate Similarity | NPC37428 |
0.8102 | Intermediate Similarity | NPC144512 |
0.8102 | Intermediate Similarity | NPC137262 |
0.8102 | Intermediate Similarity | NPC47040 |
0.8102 | Intermediate Similarity | NPC278600 |
0.8102 | Intermediate Similarity | NPC35501 |
0.8099 | Intermediate Similarity | NPC142863 |
0.8099 | Intermediate Similarity | NPC249942 |
0.8099 | Intermediate Similarity | NPC180477 |
0.8099 | Intermediate Similarity | NPC297886 |
0.8095 | Intermediate Similarity | NPC298796 |
0.8092 | Intermediate Similarity | NPC243688 |
0.8088 | Intermediate Similarity | NPC246177 |
0.8088 | Intermediate Similarity | NPC317045 |
0.8085 | Intermediate Similarity | NPC287275 |
0.8077 | Intermediate Similarity | NPC93219 |
0.8077 | Intermediate Similarity | NPC4164 |
0.8077 | Intermediate Similarity | NPC244495 |
0.8074 | Intermediate Similarity | NPC274121 |
0.8074 | Intermediate Similarity | NPC50898 |
0.8074 | Intermediate Similarity | NPC78540 |
0.8074 | Intermediate Similarity | NPC213216 |
0.8071 | Intermediate Similarity | NPC36181 |
0.806 | Intermediate Similarity | NPC19157 |
0.806 | Intermediate Similarity | NPC113006 |
0.8045 | Intermediate Similarity | NPC12694 |
0.8042 | Intermediate Similarity | NPC161864 |
0.8042 | Intermediate Similarity | NPC469933 |
0.8042 | Intermediate Similarity | NPC208303 |
0.8033 | Intermediate Similarity | NPC233238 |
0.803 | Intermediate Similarity | NPC157212 |
0.803 | Intermediate Similarity | NPC2401 |
0.8029 | Intermediate Similarity | NPC47815 |
0.8029 | Intermediate Similarity | NPC194281 |
0.8029 | Intermediate Similarity | NPC127447 |
0.8029 | Intermediate Similarity | NPC231772 |
0.8029 | Intermediate Similarity | NPC473887 |
0.8029 | Intermediate Similarity | NPC13408 |
0.8029 | Intermediate Similarity | NPC234133 |
0.8029 | Intermediate Similarity | NPC474886 |
0.8029 | Intermediate Similarity | NPC29353 |
0.8029 | Intermediate Similarity | NPC124784 |
0.8028 | Intermediate Similarity | NPC153758 |
0.8028 | Intermediate Similarity | NPC154217 |
0.8016 | Intermediate Similarity | NPC96705 |
0.8016 | Intermediate Similarity | NPC265547 |
0.8015 | Intermediate Similarity | NPC172262 |
0.8015 | Intermediate Similarity | NPC66705 |
0.8015 | Intermediate Similarity | NPC61499 |
0.8015 | Intermediate Similarity | NPC298900 |
0.8014 | Intermediate Similarity | NPC112791 |
0.8014 | Intermediate Similarity | NPC470216 |
0.8014 | Intermediate Similarity | NPC470296 |
0.8014 | Intermediate Similarity | NPC196459 |
0.8014 | Intermediate Similarity | NPC71739 |
0.8014 | Intermediate Similarity | NPC94794 |
0.8014 | Intermediate Similarity | NPC188632 |
0.8014 | Intermediate Similarity | NPC87609 |
0.8 | Intermediate Similarity | NPC128216 |
0.8 | Intermediate Similarity | NPC163398 |
0.8 | Intermediate Similarity | NPC140521 |
0.7986 | Intermediate Similarity | NPC469932 |
0.7986 | Intermediate Similarity | NPC155552 |
0.7986 | Intermediate Similarity | NPC254994 |
0.7984 | Intermediate Similarity | NPC13007 |
0.7984 | Intermediate Similarity | NPC257188 |
0.7972 | Intermediate Similarity | NPC140120 |
0.7971 | Intermediate Similarity | NPC266597 |
0.7971 | Intermediate Similarity | NPC319870 |
0.7971 | Intermediate Similarity | NPC148738 |
0.7971 | Intermediate Similarity | NPC73078 |
0.7971 | Intermediate Similarity | NPC250266 |
0.7971 | Intermediate Similarity | NPC103001 |
0.7971 | Intermediate Similarity | NPC327612 |
0.7969 | Intermediate Similarity | NPC235190 |
0.7969 | Intermediate Similarity | NPC180006 |
0.7969 | Intermediate Similarity | NPC163200 |
0.7969 | Intermediate Similarity | NPC319378 |
0.7967 | Intermediate Similarity | NPC266116 |
0.7958 | Intermediate Similarity | NPC178627 |
0.7958 | Intermediate Similarity | NPC1886 |
0.7958 | Intermediate Similarity | NPC469935 |
0.7958 | Intermediate Similarity | NPC196137 |
0.7955 | Intermediate Similarity | NPC95034 |
0.7955 | Intermediate Similarity | NPC22783 |
0.7955 | Intermediate Similarity | NPC142087 |
0.7953 | Intermediate Similarity | NPC281356 |
0.7953 | Intermediate Similarity | NPC295259 |
0.7943 | Intermediate Similarity | NPC293852 |
0.7943 | Intermediate Similarity | NPC62840 |
0.7943 | Intermediate Similarity | NPC217083 |
0.7943 | Intermediate Similarity | NPC59739 |
0.7943 | Intermediate Similarity | NPC299080 |
0.7943 | Intermediate Similarity | NPC185127 |
0.7943 | Intermediate Similarity | NPC214236 |
0.7943 | Intermediate Similarity | NPC78803 |
0.7941 | Intermediate Similarity | NPC57601 |
0.7939 | Intermediate Similarity | NPC249836 |
0.7939 | Intermediate Similarity | NPC232692 |
0.7939 | Intermediate Similarity | NPC202594 |
0.7937 | Intermediate Similarity | NPC45104 |
0.7931 | Intermediate Similarity | NPC151973 |
0.7929 | Intermediate Similarity | NPC31081 |
0.7929 | Intermediate Similarity | NPC245219 |
0.7926 | Intermediate Similarity | NPC469956 |
0.7923 | Intermediate Similarity | NPC273772 |
0.7923 | Intermediate Similarity | NPC154176 |
0.7923 | Intermediate Similarity | NPC290605 |
0.7923 | Intermediate Similarity | NPC173350 |
0.7923 | Intermediate Similarity | NPC109675 |
0.7923 | Intermediate Similarity | NPC248786 |
0.792 | Intermediate Similarity | NPC296526 |
0.7914 | Intermediate Similarity | NPC201395 |
0.791 | Intermediate Similarity | NPC113098 |
0.791 | Intermediate Similarity | NPC327457 |
0.791 | Intermediate Similarity | NPC86774 |
0.7902 | Intermediate Similarity | NPC470322 |
0.7902 | Intermediate Similarity | NPC181388 |
0.7899 | Intermediate Similarity | NPC38874 |
0.7899 | Intermediate Similarity | NPC116775 |
0.7899 | Intermediate Similarity | NPC187432 |
0.7899 | Intermediate Similarity | NPC216361 |
0.7899 | Intermediate Similarity | NPC281917 |
0.7899 | Intermediate Similarity | NPC471068 |
0.7899 | Intermediate Similarity | NPC471069 |
0.7899 | Intermediate Similarity | NPC256042 |
0.7895 | Intermediate Similarity | NPC185066 |
0.7895 | Intermediate Similarity | NPC167463 |
0.7895 | Intermediate Similarity | NPC2596 |
0.7895 | Intermediate Similarity | NPC46192 |
0.7891 | Intermediate Similarity | NPC230951 |
0.7891 | Intermediate Similarity | NPC168050 |
0.7891 | Intermediate Similarity | NPC14177 |
0.7883 | Intermediate Similarity | NPC248872 |
0.7874 | Intermediate Similarity | NPC74821 |
0.7872 | Intermediate Similarity | NPC14871 |
0.7872 | Intermediate Similarity | NPC105648 |
0.7868 | Intermediate Similarity | NPC83535 |
0.7868 | Intermediate Similarity | NPC31849 |
0.7868 | Intermediate Similarity | NPC205797 |
0.7868 | Intermediate Similarity | NPC1220 |
0.7868 | Intermediate Similarity | NPC142563 |
0.7868 | Intermediate Similarity | NPC469952 |
0.7868 | Intermediate Similarity | NPC291551 |
0.7868 | Intermediate Similarity | NPC469955 |
0.7868 | Intermediate Similarity | NPC141822 |
0.7868 | Intermediate Similarity | NPC241165 |
0.7863 | Intermediate Similarity | NPC107846 |
0.7863 | Intermediate Similarity | NPC221798 |
0.7863 | Intermediate Similarity | NPC6888 |
0.7863 | Intermediate Similarity | NPC78446 |
0.7863 | Intermediate Similarity | NPC27671 |
0.7863 | Intermediate Similarity | NPC98509 |
0.7863 | Intermediate Similarity | NPC291899 |
0.7863 | Intermediate Similarity | NPC201667 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC229113 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD3225 | Approved |
0.8898 | High Similarity | NPD3268 | Approved |
0.88 | High Similarity | NPD2797 | Approved |
0.8651 | High Similarity | NPD3267 | Approved |
0.8651 | High Similarity | NPD3266 | Approved |
0.8504 | High Similarity | NPD1203 | Approved |
0.8333 | Intermediate Similarity | NPD422 | Phase 1 |
0.8268 | Intermediate Similarity | NPD9717 | Approved |
0.8222 | Intermediate Similarity | NPD4308 | Phase 3 |
0.8188 | Intermediate Similarity | NPD3750 | Approved |
0.8182 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8136 | Intermediate Similarity | NPD9697 | Approved |
0.8088 | Intermediate Similarity | NPD7033 | Discontinued |
0.7986 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7956 | Intermediate Similarity | NPD3748 | Approved |
0.7926 | Intermediate Similarity | NPD4307 | Phase 2 |
0.791 | Intermediate Similarity | NPD2313 | Discontinued |
0.7899 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7895 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7891 | Intermediate Similarity | NPD1778 | Approved |
0.7874 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7868 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7868 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7847 | Intermediate Similarity | NPD5403 | Approved |
0.7846 | Intermediate Similarity | NPD1608 | Approved |
0.7832 | Intermediate Similarity | NPD5401 | Approved |
0.7823 | Intermediate Similarity | NPD5535 | Approved |
0.7778 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7769 | Intermediate Similarity | NPD1535 | Discovery |
0.7755 | Intermediate Similarity | NPD7411 | Suspended |
0.7734 | Intermediate Similarity | NPD1894 | Discontinued |
0.7714 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7714 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.771 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7708 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.766 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7647 | Intermediate Similarity | NPD6798 | Discontinued |
0.7647 | Intermediate Similarity | NPD411 | Approved |
0.763 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7619 | Intermediate Similarity | NPD3226 | Approved |
0.7615 | Intermediate Similarity | NPD17 | Approved |
0.7609 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7609 | Intermediate Similarity | NPD447 | Suspended |
0.7609 | Intermediate Similarity | NPD1933 | Approved |
0.7586 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7586 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7571 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7557 | Intermediate Similarity | NPD3496 | Discontinued |
0.7552 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD1511 | Approved |
0.7517 | Intermediate Similarity | NPD6799 | Approved |
0.75 | Intermediate Similarity | NPD1610 | Phase 2 |
0.75 | Intermediate Similarity | NPD3749 | Approved |
0.75 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7483 | Intermediate Similarity | NPD5402 | Approved |
0.7482 | Intermediate Similarity | NPD4340 | Discontinued |
0.7481 | Intermediate Similarity | NPD1019 | Discontinued |
0.748 | Intermediate Similarity | NPD968 | Approved |
0.7464 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7447 | Intermediate Similarity | NPD2799 | Discontinued |
0.7442 | Intermediate Similarity | NPD9493 | Approved |
0.7431 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7424 | Intermediate Similarity | NPD3847 | Discontinued |
0.7415 | Intermediate Similarity | NPD1512 | Approved |
0.7413 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.741 | Intermediate Similarity | NPD1240 | Approved |
0.7405 | Intermediate Similarity | NPD5585 | Approved |
0.7394 | Intermediate Similarity | NPD2935 | Discontinued |
0.7394 | Intermediate Similarity | NPD2796 | Approved |
0.7391 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7383 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7372 | Intermediate Similarity | NPD2614 | Approved |
0.7368 | Intermediate Similarity | NPD1091 | Approved |
0.7368 | Intermediate Similarity | NPD4288 | Approved |
0.7368 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7361 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7357 | Intermediate Similarity | NPD6355 | Discontinued |
0.7353 | Intermediate Similarity | NPD2798 | Approved |
0.7351 | Intermediate Similarity | NPD6801 | Discontinued |
0.7343 | Intermediate Similarity | NPD2346 | Discontinued |
0.7328 | Intermediate Similarity | NPD9545 | Approved |
0.732 | Intermediate Similarity | NPD7768 | Phase 2 |
0.732 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7319 | Intermediate Similarity | NPD7095 | Approved |
0.731 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7305 | Intermediate Similarity | NPD1607 | Approved |
0.7303 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7303 | Intermediate Similarity | NPD7819 | Suspended |
0.729 | Intermediate Similarity | NPD3251 | Approved |
0.728 | Intermediate Similarity | NPD290 | Approved |
0.7273 | Intermediate Similarity | NPD7075 | Discontinued |
0.7273 | Intermediate Similarity | NPD6099 | Approved |
0.7273 | Intermediate Similarity | NPD6100 | Approved |
0.7273 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7266 | Intermediate Similarity | NPD3764 | Approved |
0.7255 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7255 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7246 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD1243 | Approved |
0.7239 | Intermediate Similarity | NPD1611 | Approved |
0.7219 | Intermediate Similarity | NPD6599 | Discontinued |
0.7219 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7215 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7214 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7209 | Intermediate Similarity | NPD1241 | Discontinued |
0.72 | Intermediate Similarity | NPD3134 | Approved |
0.7194 | Intermediate Similarity | NPD4625 | Phase 3 |
0.719 | Intermediate Similarity | NPD1465 | Phase 2 |
0.719 | Intermediate Similarity | NPD2801 | Approved |
0.7174 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7171 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7163 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7162 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD1358 | Approved |
0.7143 | Intermediate Similarity | NPD9267 | Approved |
0.7143 | Intermediate Similarity | NPD9264 | Approved |
0.7143 | Intermediate Similarity | NPD9263 | Approved |
0.7133 | Intermediate Similarity | NPD4978 | Clinical (unspecified phase) |
0.7133 | Intermediate Similarity | NPD7097 | Phase 1 |
0.7132 | Intermediate Similarity | NPD4359 | Approved |
0.7132 | Intermediate Similarity | NPD4749 | Approved |
0.7124 | Intermediate Similarity | NPD1934 | Approved |
0.7113 | Intermediate Similarity | NPD1184 | Approved |
0.7105 | Intermediate Similarity | NPD6585 | Discontinued |
0.7103 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7103 | Intermediate Similarity | NPD6005 | Phase 3 |
0.7103 | Intermediate Similarity | NPD6003 | Clinical (unspecified phase) |
0.7103 | Intermediate Similarity | NPD6006 | Clinical (unspecified phase) |
0.7103 | Intermediate Similarity | NPD2344 | Approved |
0.7103 | Intermediate Similarity | NPD6004 | Phase 3 |
0.7103 | Intermediate Similarity | NPD6002 | Phase 3 |
0.7099 | Intermediate Similarity | NPD6671 | Approved |
0.7095 | Intermediate Similarity | NPD7440 | Discontinued |
0.7095 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.709 | Intermediate Similarity | NPD4626 | Approved |
0.7087 | Intermediate Similarity | NPD9266 | Approved |
0.7087 | Intermediate Similarity | NPD74 | Approved |
0.7086 | Intermediate Similarity | NPD1653 | Approved |
0.7081 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7078 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7075 | Intermediate Similarity | NPD7003 | Approved |
0.7059 | Intermediate Similarity | NPD5890 | Approved |
0.7059 | Intermediate Similarity | NPD5889 | Approved |
0.705 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7042 | Intermediate Similarity | NPD1613 | Approved |
0.7042 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.704 | Intermediate Similarity | NPD5909 | Discontinued |
0.7034 | Intermediate Similarity | NPD4477 | Approved |
0.7034 | Intermediate Similarity | NPD4476 | Approved |
0.7034 | Intermediate Similarity | NPD6032 | Approved |
0.7029 | Intermediate Similarity | NPD6362 | Approved |
0.7027 | Intermediate Similarity | NPD2354 | Approved |
0.7021 | Intermediate Similarity | NPD1048 | Approved |
0.702 | Intermediate Similarity | NPD920 | Approved |
0.7007 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD4618 | Approved |
0.6993 | Remote Similarity | NPD4622 | Approved |
0.6993 | Remote Similarity | NPD6502 | Phase 2 |
0.6986 | Remote Similarity | NPD6800 | Clinical (unspecified phase) |
0.698 | Remote Similarity | NPD6666 | Approved |
0.698 | Remote Similarity | NPD6667 | Approved |
0.6968 | Remote Similarity | NPD8455 | Phase 2 |
0.6957 | Remote Similarity | NPD1283 | Approved |
0.6954 | Remote Similarity | NPD6273 | Approved |
0.695 | Remote Similarity | NPD5163 | Phase 2 |
0.6948 | Remote Similarity | NPD2366 | Approved |
0.6944 | Remote Similarity | NPD6653 | Approved |
0.6939 | Remote Similarity | NPD7596 | Clinical (unspecified phase) |
0.6928 | Remote Similarity | NPD8158 | Clinical (unspecified phase) |
0.6928 | Remote Similarity | NPD7458 | Discontinued |
0.6918 | Remote Similarity | NPD1537 | Approved |
0.6918 | Remote Similarity | NPD1519 | Approved |
0.6918 | Remote Similarity | NPD1538 | Phase 1 |
0.6913 | Remote Similarity | NPD2309 | Approved |
0.6909 | Remote Similarity | NPD4338 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD5689 | Approved |
0.6897 | Remote Similarity | NPD5688 | Approved |
0.6897 | Remote Similarity | NPD1536 | Approved |
0.6894 | Remote Similarity | NPD9281 | Approved |
0.6892 | Remote Similarity | NPD2976 | Clinical (unspecified phase) |
0.6889 | Remote Similarity | NPD5691 | Approved |
0.6879 | Remote Similarity | NPD3882 | Suspended |
0.6875 | Remote Similarity | NPD9265 | Clinical (unspecified phase) |
0.6871 | Remote Similarity | NPD7054 | Approved |
0.6871 | Remote Similarity | NPD2353 | Approved |
0.6871 | Remote Similarity | NPD7804 | Clinical (unspecified phase) |
0.6871 | Remote Similarity | NPD2355 | Clinical (unspecified phase) |
0.6867 | Remote Similarity | NPD6652 | Clinical (unspecified phase) |
0.6866 | Remote Similarity | NPD5536 | Phase 2 |
0.6857 | Remote Similarity | NPD5647 | Approved |
0.6853 | Remote Similarity | NPD8032 | Phase 2 |
0.6842 | Remote Similarity | NPD5049 | Phase 3 |
0.6835 | Remote Similarity | NPD6971 | Discontinued |
0.6835 | Remote Similarity | NPD8005 | Clinical (unspecified phase) |
0.6829 | Remote Similarity | NPD7472 | Approved |
0.6825 | Remote Similarity | NPD9261 | Approved |
0.6824 | Remote Similarity | NPD2424 | Discontinued |
0.6822 | Remote Similarity | NPD2684 | Approved |
0.6821 | Remote Similarity | NPD7837 | Clinical (unspecified phase) |
PubChem CID   | 54676038 |
ChEMBL   | CHEMBL1466 |
ZINC   |
Molecular Weight:   | 336.06 |
ALogP:   | -0.3078 |
MLogP:   | 2.89 |
XLogP:   | 4.227 |
# Rotatable Bonds:   | 4 |
Polar Surface Area:   | 93.06 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 2 |
# Rings:   | 4 |
# Heavy Atoms:   | 25 |